Mika Leinonen
Santhera Pharmaceuticals (Switzerland)(CH)Newcastle University(GB)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Muscle Physiology and Disorders, Neurological disorders and treatments, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research
Most-Cited Works
- → Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer(2006)1,405 cited
- → One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor(2012)957 cited
- → A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy(2011)536 cited
- → Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial(2009)458 cited
- → Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease(2013)456 cited
- → Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes(2016)132 cited